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Introduction

At the present time successful
clinical organ transplantation depends on chronic administration of
immunosuppressive agents to prevent the persistent tendency of the
recipient to reject the graft. Chronic
immunosuppression- although often successful in maintaining graft
function and viability-is frequently
associated with numerous and often
fatal complications. These associated problems include: 1) inherent
tox1c1ty of immunosuppressive
drugs per se, e.g., lmuran (hepatitis), steroids (osteoporosis, gastrointestinal bleeding, etc.) , Cytoxan
and actinomycin C ( thrombocytopenia, leukopenia) ; 2) occurrence
and persistence of low-grade rejection in the graft, e.g., endarteritis
in renal and cardiac allografts,
while function is maintained; 3) occurrence of severe and bizarre infections, usually those associated
with cellular immunity (particularly
of the viral, protozoan and fungal
varieties); and, finally, 4) spontaneous appearance of malignancy,
presumably due to the abolition of
the immunological surveillance
mechanism which is probably operative in preventing the de nova
appearance of malignancy in most
normal human beings. For these
reasons specific immunological tolerance remains the ultimate and
eventual solution to the widespread
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application of clinical organ transplantation.
Immunological Tolerance

The phenomenon of actively acquired immunological tolerance was
discovered during studies of tissue
transplantation. This term was used
to describe a specific state of unresponsiveness to an antigen or antigens in adult life as a consequence of exposure to antigen in
utero or in the neonatal period. In
a study of the immunogenetic consequences of vascular anastomoses
between cattle twins in utero, Owen
( 1945) showed that most cattle
twins at birth are erythrocyte chimeras as they possess erythrocytes of their own genotype as well
as those of the opposite twin. This
chimeric state was shown to persist
beyond the life span of the erythrocyte, suggesting that erythropoietic cells (stem cells) were exchanged in fetal life and continued
to produce erythrocytes of characteristic serological type throughout adult life.
The wide significance of Owen's
observation was emphasized by
Burnet and Fenner (1948) in a
general theory of the immune response which predicted the phenomenon of tolerance. To explain
the failure of adult animals to react immunologically to their own
tissues, these authors suggested that
the body cells possess some type of
self-marker component, and that
the capacity to recognize this self
pattern develops during embryonic
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or early postnatal life. They predicted that exposure to an antigen
in embryonic life would cause that
antigen to be recognized as self
in later life, and, consequently, no
immune response would be made to
it.
In future studies, it became apparent that erythrocyte chimerism
was not the only manifestation of
tolerance in dizygotic cattle twins
which appeared after mixture of
placental circulations. Dizygotic
cattle twins were shown to accept
skin grafts from each other, and
this mutual tolerance was specific
since skin grafts transplanted from
third parties were quickly rejected
(Anderson et al., 1951). These observations in nature set the stage
for the production of actively acquired tolerance by Medawar and
colleagues in the laboratory. These
investigators injected mouse embryos of the CBA strain in utero
through the anterior abdominal
wall with a suspension of living
spleen cell lymphocytes of the
A strain (Billingham, Brent and
Medawar, 1953). The CBA recipients, regularly accepted A-strain
skin grafts when grafted in adult
life. This tolerance of A-strain
grafts was specific, since CBA mice
tolerant of A-strain tissues easily
rejected allografts from the unrelated AU strain. At the same time,
Hasek reproduced Owen's observations in chickens by the ingenious
method of making a deliberate
synchorial parabiosis of embryos
via the chorioallantoic membrane
(Hasek, 1953). At hatching, the
parabiots were separated and were
found to be tolerant not only of
each other's red cells, but skin allografts. Subsequently, it was found
that in utero injection was unnecessary, and that intravenous injection
during the early neonatal period
also produced tolerance. In these
experiments tolerance could be
abolished by the injection of tolerant animals with lymphoid cells
from normal adult members of the
same syngeneic strain. Furthermore, careful testing showed that

the tolerant mice were, in fact,
chimeras insofar as their lymphoid
cell populations were concerned
(Billingham, 1958). Tolerance induced in the neonatal period was
frequently permanent. This was in
sharp contrast to the transient nature of the tolerance to chemical
antigens observed by a number of
other investigators when non-living,
non-replicating antigens, such as
proteins, were injected into neonatal
animals for varying periods from
birth to adulthood.
The demonstration by Smith and
Bridges ( 1958) and Mitchison
(1959) of the necessity of repeated
injections of non-replicating antigens to maintain tolerance toward
these antigens, coupled with the observation of chimerism in tolerant
mice in Medawar's experiment, emphasized the concept that persistence of antigen was necessary for
the maintenance of tolerance.
Another important aspect of tolerance induction involves the genetic relationship between the donor
and the immature host. It was
found that the more distant the
histocompatibility relationships between donor and host, the more
difficult it was to induce tolerance.
When strong histocompatibility barriers existed, large innoculums of
cells were.required, the intravenous
route was obligatory, and the
tolerance-responsive period extended only to a short time after
birth. On the other hand, when the
genetic and, therefore, antigenic disparity between donor and host was
relatively weak, such stringent requirements disappeared. In fact,
when mice of very weak histocompatibility differences were used, the
tolerance-responsive period extended even into adulthood (Shapiro et al., 1961).
Graft-Versus-Host Reaction

Just as the phenomenon of actively acquired tolerance was discovered in tissue transplantation
research, so also was the graf!-versus-host reaction (hereafter, GVH

reaction) basically an outcome of
research in immunological tolerance. Simonsen (1957) found that
adult splenic cells, when injected
into newborn or embryo chickens
and mice, produced a disease that
could only be interpreted as an outcome of an immunological response
by these grafted cells against the
host. Simultaneously, Billingham
and Brent (1957), in their attempts
to induce tolerance in newborn
mice, found that, in certain strain
combinations, all injected mice died
from a peculiar wasting disease.
They concluded that a GVH reaction was the likely explanation of
this pathological condition which
they named runt disease. GVH reactions result when a recipient of
a graft comprised of immunologically competent cells is incapable of
rejecting the cellular ·graft. This situation typically arises in very young
individuals (embryos and newborn
recipients). It also occurs in adults
when a graft from a homozygous
donor, i.e., genetically AA, is given
to a host that is an Fi hybrid between the donor strain and a dissimilar strain, i.e., genetically AB.
A graft A transplanted to an AB
host represents a situation in which
the hybrid cannot reject the graft
by immunological means even
though the host may be entirely
competent immunologically. This is
true because the graft does not
possess any antigens that are foreign to the host. The graft, however, can react against the host,
since the latter contains foreign
antigens derived from the dissimilar
parent of the hybrid.
The mouse is the classic animal
for the production of GVH reactions and runt disease. In severe reactions, mice grow normally
for about a week, but thereafter
growth ceases, and there is subsequent weight loss, associated with
diarrhea, alopecia, dermatitis and
eventual death . This pathological
condition has been demonstrated
in numerous other species. It is of
great clinical significance that human recipients of bone marrow
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transplants, especially after immunosuppressive treatment with whole
body irradiation or cytotoxic drugs,
have shown all the symptoms of
classical GVH reactions similar to
those observed in lower species. The
most important parameters which
determine severity of GVH reactions are: 1) the immune competence of the cells utilized; 2) the
dose of the cellular innoculum; and
3) the degree of histocompatibility
difference between the donor and
the recipient. The pathological
symptoms and the mortality rate
increase as these parameters increase.
Immunological Tolerance and
Antilymphocyte Serum

Induction of specific immunological tolerance to either tissue allografts or non-replicating, chemically defined antigens, such as
proteins, is by no means limited to
neonatal or immunologically incompetent young animals. Tolerance can be induced in adult, immunologically competent animals
under a number of special circumstances. For example, it may be
induced by the injection of massive
amounts of antigen (so-called immunological paralysis or antigen
overloading) or by the injection of
antigen during certain times of immunosuppression or lymphocyte
depletion. Immunological depression in adult animals to abet the
induction of tolerance has been
achieved in a number of different
ways, i.e., irradiation, cytotoxic
drugs, steroids or a combination
of these (Russell and Monaco,
1965) . In our laboratory, heterologous antilymphocyte serum (ALS)
has been used as an immunosuppressive agent to facilitate the induction of tolerance to tissue allografts in adult animals. It is the
purpose of this report to review
our experiments in this particular
area.
Heterologous ALS is an extraordinary immunosuppressive agent.
Mice treated with this reagent show
184

a dramatic inability to reject tissue
allografts and xenografts (Gray et
al., 1966; Monaco et al., 1966).
Recent evidence indicates that ALS
acts mainly on peripheral circulating lymphocytes (Taub and Lance,
1968) . The mechanism of action
of ALS continues to be uncertain,
but evidence suggests (Monaco,
Wood and Russell, 1965a) that its
immunosuppressive property depends on its effects on thymusdependent, immunologically competent lymphocytes. ALS frequently
induces peripheral lymphopenia
and tissue lymphocyte depletion,
and the treated animals are nonspecificall y immunosuppressed.
Some serums, equally immunosuppressive, do not necessarily produce
a dramatic and sustained lymphopenia. It appears, therefore, that for
ALS to be immunosuppressive, it
must act on a select group of peripheral lymphocytes which is probably quite small in number, and its
effectiveness is not dependent on
the lymphopenia per se, but rather
on the depletion or destruction of a
certain population of immunocompetent, thymus-dependent cells. Recent work suggests that ALS is
highly effective in depressing cellular-type immunities, as typified by
reaction of tissue allografts, whereas the humoral antibody response
to certain antigens, especially bacterial ones, is much less affected.
The depression of immune capability following treatment with ALS
may be due to the decreased number of mature lymphocytes and/ or
to the immune incompetence of remaining lymphocytes. From our
experiments it appears that the lymphoid cells exposed to ALS in vivo
an din vitro do not live on and replicate (Van der Werf et al., 1968),
since ,they do not induce GVH reactions in susceptible recipients or
tolerance and chimerism in neonatally injected histoincompatible
mice. This supports the concept that
the cells remaining in lymph nodes
after rabbit anti-mouse lymphocyte
serum (RAMLS) treatment are immunologically incompetent. These

remammg cells (or their descendents) eventually become immunologically competent, perhaps under
the influence of the thymus or a
thymic product.
Experiments have been done in
mice and rats to determine whether
or not tolerance is a property associated with the thymus or thymusderived cells. Galton, Reed and Holt
(1964) showed that allograft tolerance occurs with the achievement
of thymic chimerism. This suggested that the presence of allogeneic cells within the thymus
is essential for the induction
and maintenance of a tolerant state
and that the target cell for tolerance induction must be the lymphoid precursor cell within the
thymus. The presence of the antigen within the thymus and the existence of tolerance may, however,
be coincidental, as has been suggested by Miller and Osoba ( 1967).
Other investigators (Follett, Battisto and Bloom, 1966) have shown
that the lymphoid system in adultthymectomized animals can be
rendered specifically tolerant to defined antigens. Thus, the presence of the thymus is not necessary
for tolerance induction. This does
not exclude the lymphoid precursor
cells as the target cells for tolerance induction. These may be present in the thymus-dependent areas
of lymphoid organs (Holborrow,
1968) and be influenced by a thymic humoral factor (Hardy et al.,
1968). The breakdown of tolerance
occurs when immunologically competent cells are recruited from precursors which have not been exposed to the tolerance-inducing antigen. This recruitment appears to
be dependent on the thymus or on
a thymic humoral factor. Claman
and Talmage ( 1963) showed that,
in mice previously rendered tolerant to horse serum albumin, adult
thymectomy delayed the spontaneous escape from tolerance. Argyris
( 1965) showed that the transplantation of C3H/ He thymus tissue
accelerated the breakdown of tolerance in C3H/ He mice tolerant
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the abolishment of a tolerant state,
presumably by its influence on the
development and the recruitment of
immunologically competent cells.
Although ALS is highly effective
in depressing cellular type immunities-as typified by rejection of tissue allografts-while preserving
relatively intact the humoral anti-

to CBA skin grafts. Goldstein et
al. have recently shown that tolerance to A l Jax skin in neonatally
thymectomized CBA mice can be
abolished by a thymic humoral factor (unpublished data). It appears,
therefore, that the thymus or a thymic humoral factor plays an important role in the induction and

EXPERIMENTAL

PRODUCTION OF CHIMERAS

0
A/Jax

7.
,
.
.
,
r
,
.
.
,
0
0
Thym

Thymectomy

Anti-lymphocyte serum

Spleen +Lymph node cell
suspension

0

300xl06cells i.v.

300xl06cells i.v.

t
Spleen cells

0

I

Lymph node cells

I

F1 Hybrid

NO
TOLERANCE

TOLERANCE

Fig. I-The experimental production of chimeras and specific immunological
tolerance with antilymphocyte serum. (Reprinted from Monaco, Wood and
Russell, 1966.)

body responses to certain bacterial
antigens, it must be emphasized that
ALS-induced suppression of tissue
graft rejection is still nonspecific.
Thus, third-party allografts placed
on mice treated with ALS while an
earlier test allograft is alive are rejected at the same time as the test
allografts (Monaco et al., 1966).
Furthermore, adult thymectomy
and ALS treatment produce a prolonged period of nonspecific immune incompetence in the capacity
to express cellular type immunities. Adult-thymectomized, ALStreated mice frequently bear healthy
allografts for over 100 days. Thirdparty grafts applied at that time
also frequently show prolonged
survival. This profound immune incompetence induced by adult thymectomy and ALS seemed analogous to the unresponsiveness seen
in neonatally thymectomized mice.
Because of this similarity, we felt
it might be possible to induce tolerance in adult animals treated in
this manner.
In the initial experiments (Monaco, Wood and Russell, 1966)
adult-thymectomized and normal
A l Jax mice were treated with ALS
and infused with C3H/ He X A/ Jax
Fi hybrid cells intravenously. Fi hybrid cells were used to avoid a GVH
reaction (Fig. 1). C3H/He skin allografts in adult-thymectomized,
ALS-treated, cell-infused mice
showed a markedly prolonged survival , as compared to a dultthymectomized animals receiving
ALS but no cell infusion. Furthermore, thymectomized, ALS-treated,
cell-infused mice rejected thirdparty C57BL/ 6 J skin in a normal
fashion while retaining their first
and, even, second C3H/ He skin
allografts (Fig. 2). This emphasized
the fact that they were specifically
tolerant to C3H/ He tissues. These
tolerant mice were found to be lymphoid cell chimeras, · containing
lymphocytes of both A/ Jax and
C3H/He genotypes. The tolerance
was abolished by injection of normal (syngeneic) A/ Jax lymphocytes, a finding similar to that noted
185
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by Medawar and colleagues in their
tolerance experiments in neonatal
animals. This acquired state of
tolerance associated with a state of
lymphoid cell chimerism was seen
in all the thymectomized mice
which received both ALS and a
cell infusion.
Since hybrid donor lymphoid
cells would never be available in
clinical situations, attempts were
made to reproduce the above experiment using non-hybrid (homozygous) allogeneic lymphoid ceHs.
Severe GVH reactions resulted
when high doses (300 x 10 6 ) of
cells were used. To avoid the GVH
reaction, we used allogeneic histocompatibility antigens in a cell-free
form from the supernatant of
mechanically disrupted spleen cells

(Monaco, Wood and Russell,
1965b) of the skin graft donor.
The addition of this cell-free antigen (CPA) to a course of ALS increased the prolongation of skin allografts slightly over that achieved
with ALS alone. The addition of
CPA to a course of ALS in adultthymectomized mice almost doubled skin allograft survival as compared to that in ALS-treated
thymectomized mice (Abbott,
Monaco and Russell, 1969). Of
major importance was the finding
that third-party grafts were rejected
relatively normally in the thymectomized animals receiving ALS and
CF A, and, therefore, the prolonged
survival of the original allograft
was a form of specific acquired tolerance in the adult.

The tolerance induced with CPA
in such lymphocyte-depleted animals may be long lasting but is not
permanent. Furthermore, the number of animals in any group showing a great degree of tolerance is
less than when replicating lymphoid
cells are used as the donor antigen.
Presumably this results from a regeneration or increase in the number of immunologically competent
cells which can, again, react to the
foreign antigen. Since these cells
are probably thymus-dependent, as
we indicated earlier in this article,
one may justifiably question the
reappearance of immunocompetent
cells in an ALS-treated thymectomized mouse. It is probable that a
small number of immunologically
competent cells can regenerate from

Fig. 2- A. An adult-thymectomized A/ Jax mouse which received ALS for seven days followed by 300 x lQG C3H/ He lymphoid cells, as in Figure 1. The mouse bears a C3H/ He graft in perfect condition for 100 days.
B. The same mouse bearing the same first C3H/ He graft as well as a second C3H/ He graft on day 150.

C. A similar adult-thymectomized, ALS-treated, cell-infused mouse bearing a perfect C3H/ He graft over 100 days but
simultaneously rejecting a third-party C57Bl / 6J skin allograft-i.e., indicating specific tolerance.
D. The mouse visualized in B after infusion with normal syngeneic A/Jax lymphoid cells, showing rejection of previously well-tolerated C3H/ He grafts-Le., the abolition of specific tolerance.
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IMMUNOLOGICA L TO LE RANCE AND ANT ILYM PHOCYTE SERUM

the bone marrow in the absence of
the thymus. Another possibility is
that residual stem cells in the peripheral lymphoid system (lymph
nodes, Peyer's patches, etc.) may
differentiate to immunologically
competent cells under the influence
of a thymic humoral factor which
persists in such tissues after thymectomy. It may be possible to
circumvent this regeneration by the
addition of small doses of immunosuppressive agents (perhaps in
association with specific antigen) to
prevent the regeneration of new
immunocompetent cells. Apparently, when a chimeric state is
established, regeneration of competent cells and loss of the tolerant
state is delayed or prevented by
persisting donor antigen in the
form of chimeric lymphoid cells.
Until recently we were unable
to induce any form of specific tolerance in the non-thymectomized,
ALS-treated adult mice. On the
contrary, we found that such animals were sensitized after infusion
with allogeneic F1 hybrid lymphoid
cells. These seemingly incompatible
results may be explained by Mitchison's ( 1965) elegant demonstration
that the antigen dose frequently
determines whether tolerance or
sensitization results from antigen
introduction. This investigator
showed that tolerance to bovine
serum albumin in mice resulted
when the protein was administered
in two dose zones, i.e., in high and
low ranges. Doses in other ranges
either produced sensitization or no
effect. The concept of high zone and
low zone tolerance was thus introduced. We tested the effects of various doses (0.01, 0.1, 1.0, 10 and
100 X 10 6 ) of homozygous allogeneic C3HjHe lymphoid cells in
five groups of ALS-pretreated (nonthymectomized) A/ Jax mice. Controls received ALS but no cells.
Figure 3 shows the survival curves
of the test allografts in the various
groups. C3HjHe skin allografts survived longest in AjJ ax mice which
received 10 x 10 6 cells, thus indicating a potentiation of ALS immuno-
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Fig. 3-Survival curves of C3H/ He skin allografts on ALS-treated A/ Jax mice
infused with various doses of C3H/ He allogeneic, non-F1 hybrid lymphoid cells.
(Monaco, in press, 1969.)
suppression by cell infusion, i.e.,
partial tolerance. The grafts in the
groups receiving 0.1 X 10 6 or 100
X 10 6 had a shorter survival time
than the ALS controls, indicating
a partial sensitization by this dose
of cell infusion. Mice receiving .01
x 10 6 or 1 x 10 6 cells rejected
their grafts at the same time as the
controls treated with ALS alone,
showing that there was no effect of
doses of cells in these ranges. These
observations in ALS-treated mice
receiving cell infusions are analogous to those of Mitchison on various protein antigens in which the
resulting reactions of sensitization
and/ or tolerance are probably dependent on the dose of antigen
utilized. Of importance in these
experiments, from the point of view
of potential clinical application, was
the observation that in these lower

dose ranges where partial tolerance
resulted, there was little if any observed GVH reaction.
Lance and Medawar (1969), in
a similar experiment, have emphasized the effect of the timing of
injections of cells on the probability
of their potentiating or sensitizing
the recipient of the graft. Furthermore, these investigators demonstrated that GVH reactions can be
avoided by using cells with decreased immune competence, i.e.,
thymocytes, bone marrow cells, and
cells from ALS-treated donors.
That this phenomenon of acquired partial tolerance induced
with donor antigen is not peculiar
to skin allografts in mice is well
established. Organ allografts appear to be less antigenic than skin
allografts; hence, it will probably
·be easier to develop a tolerant state
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to an organ allograft than to a
skin allograft. We must further remember that organs are attached by
direct vascular anastomosis and
that the antigen is chronically released. This may be important in
maintaining a tolerant state. Thus,
a permanent state of chimerism
might not be necessary to achieve
a permanent state of tolerance.
Seifert et al. (1966) obtained significant improvement in renal allografts by pretreating dogs with
subcellular (cell-free) antigen and
6-mercaptopurine and a dding
methylprednisolone after transplantation. Dagher et al. ( 1967)
used a two-week pretreatment
course with soluble cytoplasmic antigen from viable donor spleen cells
and demonstrated a prolonged renal
allograft survival in dogs when
minimal doses of azathioprine and
methylprednisolone were given after
renal transplantation. These studies
of whole organ allograft survival
suggest that the prolongation was
augumented by the donor antigen.
The use of specific donor antigen
appears promising as an adjunct
in immunosuppressive therapy of
whole organ allografts.
Conclusion
Our interest in the problem of
tolerance induction is directly concerned with clinical organ transplantation. ALS is highly effective
in depressing cellular immunities.
Since at least initial allograft rejection is predominantly a cellular
phenomenon, one would expect
ALS to be highly effective clinically.
Our initial observations in this regard support this concept. However,
non-specific depression of cellular
immunity may also lead to an increased number of viral, fungal,
and protozoan infections. Experiments, such as those presented,
strongly suggest that a specific state
of tolerance to organ grafts in man
should be attainable with the aid of
ALS followed by introduction of
appropriate antigen. A number of
avenues are open to increase the
likelihood of success for clinical in188

duction of tolerance. Improved
methods of histocompatibility typing will aid in tolerance induction,
since tolerance is more easily established when histocompatibility differences are minimized. Much effort
is being expended in isolation of human cell-free histocompatibility antigens in a soluble form (Kahan and
Reisfeld, 1969). Experimental evidence so far suggests that soluble
antigens are less immunogenic and
more tolerogenic. Development of
optimal (non-sensitizing, tolerogenic) antigenic dose schedules-to
be administered after immunosuppression has been achieved-should
facilitate clinical tolerance induction. If antigens are utilized in a
cellular form-as is our tendency at
present-then replicating lymphoid
cells from ALS-treated donors, replicating non-immunologically competent cells ( thymocytes, bone
marrow cells), or nonreplicating
parenchymal cells of appropriate
organs (liver, kidney, etc.) might,
theoretically, be utilized. It is apparent that organ transplantation
cannot be fully applied until the
problem of specific allograft tolerance is solved. A practical solution to the problem may be closer
at hand than we realize.
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